Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Nrc Health (NRC) Shares Repurchased (2022 - 2026)

Nrc Health's Shares Repurchased history spans 5 years, with the latest figure at $1000.0 for Q4 2025.

  • On a quarterly basis, Shares Repurchased fell 99.99% to $1000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $20.2 million, a 34.79% decrease, with the full-year FY2025 number at $20.2 million, down 34.79% from a year prior.
  • Shares Repurchased hit $1000.0 in Q4 2025 for Nrc Health, down from $9.3 million in the prior quarter.
  • Over the last five years, Shares Repurchased for NRC hit a ceiling of $15.5 million in Q2 2022 and a floor of $1000.0 in Q4 2025.
  • Historically, Shares Repurchased has averaged $6.5 million across 4 years, with a median of $6.0 million in 2025.
  • Biggest five-year swings in Shares Repurchased: soared 2666.67% in 2024 and later plummeted 99.99% in 2025.
  • Tracing NRC's Shares Repurchased over 4 years: stood at $2.3 million in 2022, then skyrocketed by 547.35% to $15.0 million in 2023, then plummeted by 50.68% to $7.4 million in 2024, then plummeted by 99.99% to $1000.0 in 2025.
  • Business Quant data shows Shares Repurchased for NRC at $1000.0 in Q4 2025, $9.3 million in Q3 2025, and $6.0 million in Q2 2025.